Outstaying their Welcome: The Persistent Myofibroblast in IPF.
نویسندگان
چکیده
As noted, the unrestrained accumulation of myofibroblasts is a key feature that differentiates fibrotic from physiologic repair. The accrual of these cells represents the combined effects of cell trafficking, proliferation and death. Of these, proliferation has received considerable attention; indeed, fibroblastic foci were initially defined as “small aggregates of actively proliferating fibroblasts and myofibroblasts” [11,12]. Certainly, studies suggest that fibroblast proliferation is important, especially in the early phases of wound repair and fibrosis [13]. Moreover, soluble mediators implicated in fibrosis have been shown to induce fibroblast proliferation in vitro [14-16]. Comparisons of IPF and normal lung fibroblasts, however, have shown variable results, and some studies suggest that IPF fibroblasts actually have a decreased rate of proliferation [17,18]. Moreover, studies of IPF tissue have demonstrated that while there is substantial epithelial cell proliferation, there is little to suggest robust fibroblast proliferation within fibroblastic foci [19,20].
منابع مشابه
Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis
The contribution of epithelial-to-mesenchymal transition (EMT) to the profibrotic stiff microenvironment and myofibroblast accumulation in pulmonary fibrosis remains unclear. We examined EMT-competent lung epithelial cells and lung fibroblasts from control (fibrosis-free) donors or patients with idiopathic pulmonary fibrosis (IPF), which is a very aggressive fibrotic disorder. Cells were cultur...
متن کاملSimvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts.
Simvastatin is best known for its antilipidemic action and use in cardiovascular disease due to its inhibition of 3-hydroxy-3-methylglutaryl CoenzymeA (HMG CoA) reductase, a key enzyme in the cholesterol synthesis pathway. Inhibition of biological precursors in this pathway also enables pleiotrophic immunomodulatory and anti-inflammatory capabilities, including modulation of growth factor expre...
متن کاملInvolvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
Fibroblastic foci, known to be the leading edge of fibrosis development in idiopathic pulmonary fibrosis (IPF), are composed of fibrogenic myofibroblasts. Autophagy has been implicated in the regulation of myofibroblast differentiation. Insufficient mitophagy, the mitochondria-selective autophagy, results in increased reactive oxygen species, which may modulate cell signaling pathways for myofi...
متن کاملThe K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
BACKGROUND Idiopathic pulmonary fibrosis (IPF) is a common, progressive and invariably lethal interstitial lung disease with no effective therapy. We hypothesised that K(Ca)3.1 K(+) channel-dependent cell processes contribute to IPF pathophysiology. METHODS K(Ca)3.1 expression in primary human lung myofibroblasts was examined using RT-PCR, western blot, immunofluorescence and patch-clamp elec...
متن کاملPirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
BACKGROUND Pirfenidone (PFD) is an anti-fibrotic agent used to treat idiopathic pulmonary fibrosis (IPF), but its precise mechanism of action remains elusive. Accumulation of profibrotic myofibroblasts is a crucial process for fibrotic remodeling in IPF. Recent findings show participation of autophagy/mitophagy, part of the lysosomal degradation machinery, in IPF pathogenesis. Mitophagy has bee...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Austin journal of pulmonary and respiratory medicine
دوره 1 1 شماره
صفحات -
تاریخ انتشار 2014